Cited by 618Receptor Mechanisms and SignalingCardiac Fibrosis and RemodelingCardiomyopathy and Myosin Studies

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

Norepinephrine-stimulated hypertrophy of cultured rat myocardial cells is an alpha-1 adrenergic response

Open access

Simpson, P·1983·Journal of Clinical Investigation

Open this paper in CoChat — free account Open PDF

Abstract

We have shown recently that norepinephrine stimulates muscle cell hypertrophy in primary cultures from the neonatal rat ventricle and that this stimulation is not blocked by the beta adrenergic antagonist propranolol. The present study was done to define the adrenergic specificity of the myocyte hypertrophic response to norepinephrine. 90% pure, single-cell cultures of nongrowing myocytes were maintained in serum-free medium 199 with transferin and insulin. Myocyte size was quantitated 48 h after addition of adrenergic agents, by measuring cell volume, cell surface area, and cell protein. L-norepinephrine increased myocyte size to a maximum 150% of control; half-maximum effect was obtained at a concentration of 0.2 microM. This increase in cell size was inhibited by the nonselective alpha adrenergic antagonist phentolamine and by the alpha 1 adrenergic antagonists prazosin and terazosin; it was not inhibited by propranolol or by the alpha 2 adrenergic antagonist yohimbine. The beta adrenergic agonist isoproterenol did not increase cell size. Thus, norepinephrine-stimulated hypertrophy of cultured rat myocardial cells is an alpha 1 adrenergic response.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1172/jci111023

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O. H., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 316,394
Biostatistical Analysis.
Feinleib, M., & Zar, J. H. (1975) · Journal of the American Statistical Association · doi:10.2307/2285423 · Cited by 12,671
Biostatistical analysis
Zar, J. H. (1996) · Cited by 7,837
Presynaptic regulation of the release of catecholamines.
Langer, S. Z. (1980) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06843-7 · Cited by 1,504
Differentiation of rat myocytes in single cell cultures with and without proliferating nonmyocardial cells. Cross-striations, ultrastructure, and chronotropic response to isoproterenol.
Simpson, P., & Savion, S. (1982) · Circulation Research · doi:10.1161/01.res.50.1.101 · Cited by 453
Myocyte hypertrophy in neonatal rat heart cultures and its regulation by serum and by catecholamines.
Simpson, P. C., McGrath, A., & Savion, S. (1982) · Circulation Research · doi:10.1161/01.res.51.6.787 · Cited by 429
Studies on isoproterenol-induced cardiomegaly in rats
Stanton, H. C., Brenner, G., & Mayfield, E. D. (1969) · American Heart Journal · doi:10.1016/0002-8703(69)90131-8 · Cited by 216
Cardiac Sympathetic Nerves as the Final Common Pathway in the Induction of Adaptive Cardiac Hypertrophy
Östman‐Smith, I. (1981) · Clinical Science · doi:10.1042/cs0610265 · Cited by 182
Adrenergic antagonists, and a possible link between the increase in cyclic adenosine 3′,5′‐monophosphate and DNA synthesis during liver regeneration
MacManus, J. P., Braceland, B., Youdale, T., & Whitfield, J. F. (1973) · Journal of Cellular Physiology · doi:10.1002/jcp.1040820204 · Cited by 144
Function of myocardial α-adrenoceptors
Benfey, B. G. (1990) · Life Sciences · doi:10.1016/0024-3205(90)90062-v · Cited by 122

Show all 20 references

Research works printed but not linked: 1

Kyncl, J. J., E. N. Bush, and S. A. Buckner. 1982. Alpha adrenergic blocking properties of terazosin. Fed. Proc. 41:1648.

Sorted by citations

Items 501–600 of 618

Force-Interval Relationship and Activator Calcium Availability: Similarities of Sympathetic Stimulation and Hypertrophy and Heart Failure
Anderson, P. A. W. (1987) · Developments in cardiovascular medicine · doi:10.1007/978-1-4613-2041-8_9 · Cited by 4
Gαq and its Aktions
Harris, D. M., Eckhart, A. D., & Koch, W. J. (2006) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2006.03.001 · Cited by 4
THE EFFECT OF HYPERTENSIVE EPISODES AND CARDIAC HYPERTROPHY ON THE CANINE CARDIAC BAROREFLEX
Kingwell, B. A., Krause, L. C., & Julius, S. (1994) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1994.tb02433.x · Cited by 4
Cloning and gene expression of G protein competitive inhibitory polypeptide and its prophylactic effects on myocardial hypertrophy in vitro.
Zhou, J., Li, X., Zhang, H., Tang, Y., & Wang, X. (2003) · PubMed · Cited by 4
Receptor Pharmacology of the Human Heart
Bristow, M. R., & Port, J. D. (1990) · Elsevier eBooks · doi:10.1016/b978-0-12-275820-1.50005-4 · Cited by 4
Identification of candidate cardiomyopathy modifier genes through genome sequencing and RNA profiling
Lindholm, M. E., Abramowitz, S. A., Waggott, D. M., Grove, M. E., Dewey, F. E., Pan, C., Pavlović, A., Shang, C., Huang, Y., Bensabath, L., et al. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1546493 · Cited by 3
Application of Digital Holographic Imaging to Monitor Real-Time Cardiomyocyte Hypertrophy Dynamics in Response to Norepinephrine Stimulation
Akter, W., Huang, H., Simmons, J., & Payumo, A. Y. (2024) · Applied Sciences · doi:10.3390/app14093819 · Cited by 3
Therapeutic effect on left ventricular hypertrophy by different antihypertensive drugs
Motz, W., & Strauer, B. E. (1992) · Journal of Molecular Medicine · doi:10.1007/bf00207617 · Cited by 3
The Antiarrhythmic Activity of Novel Pyrrolidin-2-one Derivative S-75 in Adrenaline-Induced Arrhythmia
Lustyk, K., Sałaciak, K., Zaręba, P., Siwek, A., Sapa, J., & Pytka, K. (2021) · Pharmaceuticals · doi:10.3390/ph14111065 · Cited by 3
Association Between Elevated Body Mass Index and Cardiac Organ Damage in Children and Adolescents: Evidence and Mechanisms
Annaloro, A., Invernizzi, C., Aguilar, F., Álvarez‐Pitti, J., Cuspidi, C., Grassi, G. M., & Lurbe, E. (2024) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-024-00633-5 · Cited by 3
Molecular Mechanisms of Myocardial Remodeling
Colucci, W. (1999) · Springer eBooks · doi:10.1007/978-0-585-38141-1_2 · Cited by 26
Catecholamine-induced cardiac hypertrophy in rats is associated with the activation of p70 kinase and c-Jun NH(2)-terminal kinase 2.
Leicht, M., Greipel, N., Raßler, B., & Zimmer, H. (2002) · PubMed Central · Cited by 3
Carvedilol blockade of rat myocardial α1-adrenoceptors
Qvigstad, E., Osnes, J., Sandnes, D., Schiander, I. G., Bøkenes, J., Sjaastad, I., & Skomedal, T. (2003) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2003.09.001 · Cited by 3
In Vivo β-adrenergic activation of atrial natriuretic factor (ANF) reporter expression
Edwards, J. G. (2006) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-006-9225-4 · Cited by 3
Medical Therapy in Heart Failure – Is Polypharmacy Necessary?
Kwok, B. W. K. (2004) · Annals of the Academy of Medicine Singapore · doi:10.47102/annals-acadmedsg.v33n4p444 · Cited by 3
Selective or nonselective β-adrenergic blockade in patients with congestive heart failure
Metra, M., Nodari, S., BOLDI, E., & Cas, L. D. (2000) · Current Cardiology Reports · doi:10.1007/s11886-000-0076-4 · Cited by 3
Risk for Cardiac Involvement in Essential Hypertension
Zahka, K. G. (1986) · Cardiology Clinics · doi:10.1016/s0733-8651(18)30638-6 · Cited by 3
Terazosin
Kynčl, J., Sonders, R. C., Sperzel, W. D., Winn, M., & Seely, J. H. (1986) · Cardiovascular Drug Reviews · doi:10.1111/j.1527-3466.1986.tb00485.x · Cited by 3
Signal Transduction in Myocardial Hypertrophy and Myosin Expression
Rupp, H., Jacob, R., & Dhalla, N. S. (1990) · Developments in cardiovascular medicine · doi:10.1007/978-1-4613-1513-1_9 · Cited by 3
Pathophysiology and Clinical Recognition of Heart Failure
Cohn, J. N. (2007) · Springer eBooks · doi:10.1007/978-1-84628-715-2_65 · Cited by 3
α-Adrenergic stimulation induces phosphorylation of retinoblastoma protein in neonatal rat ventricular myocytes
Qingquan, L. I. U., Dawes, N. J., Lu, Y., SHUBEITA, H. S., & Zhu, H. (1997) · Biochemical Journal · doi:10.1042/bj3270299 · Cited by 3
Gene Expression in Cardiac Hypertrophy
Barton, P. J. R., Boheler, K. R., Brand, N. J., & Thomas, P. S. (1995) · Medical intelligence unit · doi:10.1007/978-3-662-22192-1_5 · Cited by 3
Animal Models and Methods of Myocardial Infarction Induction and the Role of Tissue Engineering in the Regeneration of Damaged Myocardium
Fakhr, M. J., Dezfouli, M. R. M., & Chaleshtori, S. S. (2022) · Current Stem Cell Research & Therapy · doi:10.2174/1574888x17666221011085745 · Cited by 2
Impact of a Low-Dose Reserpine/Thiazide Combination on Left Ventricular Hypertrophy Assessed with Magnetic Resonance Tomography and Echocardiography
Horn, H. J., Detmar, K., Pittrow, D., Loose, R., & Weidinger, G. (1997) · Clinical Drug Investigation · doi:10.2165/00044011-199714020-00004 · Cited by 2
Molecular Biology of Heart Disease Synopsis of the Pathophysiological Basis of Cardiac Hypertrophy, Familial Hypertrophic Cardiomyopathy, Long QT Syndrome and Marfan Syndrome.
Kurabayashi, M., & Yazaki, Y. (1996) · Internal Medicine · doi:10.2169/internalmedicine.35.243 · Cited by 2
A peptide from a ras effector-domain blocks ras-dependent cardiac hypertrophy in myocytes.
Deng, L., Boujdir, M., Tremontano, A., Pincus, M. R., & El‐Sherif, N. (2009) · PubMed · Cited by 2
Early and Late Sympathetic Activation in Hypertension
Mancia, M. D. R. G. (1998) · Scandinavian Cardiovascular Journal · doi:10.1080/14017439850140283-1 · Cited by 2
Natriuretic peptides potentiate cardiac hypertrophic response to noradrenaline in rats
Jiang, D., Matsuzaki, M., Ida, T., Kitamura, K., Tsuruda, T., Kaikita, K., & Kato, J. (2023) · Peptides · doi:10.1016/j.peptides.2023.171035 · Cited by 2
Automated surface area measurement of cultured cardiac myocytes
Toraason, M. A., KRUEGER, J. A., Busch, K. A., & Shaw, P. B. (1990) · Cytotechnology · doi:10.1007/bf00365096 · Cited by 2
Influence of the Calcium Antagonist Amlodipine on Left Ventricular Mass and Function in Patients with Essential Hypertension
Cerasola, G., Nardi, E., Cottone, S., Giuliano, F., Volpe, V., & Panepinto, N. (1997) · Clinical Drug Investigation · doi:10.2165/00044011-199700131-00005 · Cited by 2
Hemodynamic Adaptive Mechanisms in Heart Failure
Hussey, A., Eastaugh, L., & Weintraub, R. G. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-802393-8.00005-3 · Cited by 2
Angiotensin‐converting enzyme inhibition, cell growth, and left ventricular hypertrophy in hypertension
Giles, T. D. (1991) · Clinical Cardiology · doi:10.1002/clc.4960141810 · Cited by 2
A soluble neuronal factor alters contractile function of ventricular myocytes without effect on troponin T isoform expression
Green, S. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(98)00217-x · Cited by 2
Clinical Applications of Alpha1‐Receptor Blockade: Terazosin in the Management of Hypertension
Rosenthal, J. H., & Kynčl, J. (1993) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1993.tb01965.x · Cited by 2
G Proteins in Heart Disease
Dorn, G. W. (1999) · Heart Failure Reviews · doi:10.1023/a:1009895301426 · Cited by 2
The nuclear receptor RORα preserves cardiomyocyte mitochondrial function by regulating mitophagy through caveolin-3Preprint
Beak, J. Y., Kang, H., Huang, W., Aghajanian, A., Gerrish, K., Jetten, A. M., & Jensen, B. C. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.10.02.323410 · Cited by 2
Interrelation between α-Cardiac Actin Treadmilling and Myocardin-Related Transcription Factor-A Nuclear Shuttling in Cardiomyocytes
Gorey, M.-A., Mericskay, M., Li, Z., & Decaux, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137394 · Cited by 1
Pathophysiologie der chronischen Herzinsuffizienz
Böhm, M., & Erdmann, E. (2000) · Springer eBooks · doi:10.1007/978-3-662-12156-6_29 · Cited by 1
Combination of Therapeutic Apheresis and Therapeutic Ventricular Assistance for End‐Stage Heart Failure Patients
Schulte-Eistrup, S., Ashizawa, S., Nonaka, K., Ichikawa, S., Motomura, T., Murai, N., & Nosé, Y. (2002) · Therapeutic Apheresis and Dialysis · doi:10.1046/j.1526-0968.2002.00444.x · Cited by 1
Role of Sympathetic Nervous System in Hypertension
Kaul, C. L., & Ramarao, P. (2003) · Progress in experimental cardiology · doi:10.1007/978-1-4419-9232-1_12 · Cited by 1
Early impact of albuminuria on cardiac function in patients with chronic kidney disease: a prospective study
Li, Y., Liu, Y., Gao, L., & Tian, C. (2024) · The International Journal of Cardiovascular Imaging · doi:10.1007/s10554-024-03056-4 · Cited by 1
Risk of intradialytic hypotension among different antihypertensives in haemodialysis patients
Chen, T., Hsieh, M. H., Su, F.-Y., Lee, C. B., Wang, M.-C., Tseng, C., Liu, K., Chiang, J.-H., & Lai, E. C. (2025) · Clinical Kidney Journal · doi:10.1093/ckj/sfaf159 · Cited by 1
Sympathetic overactivity in dialysis patients—Underappreciated and clinically consequential
Hoye, N. A., Wilson, L. C., Jardine, D. L., & Walker, R. J. (2018) · Seminars in Dialysis · doi:10.1111/sdi.12756 · Cited by 2
Isolation of Neonatal and Adult Rat Cardiomyocytes
Razzaque, A. M., & Robbins, J. M. (2013) · doi:10.1002/9781118495148.ch13 · Cited by 1
Differential Effects of Antihypertensive Agents on Proliferation of Vascular Smooth Muscle Cells from Spontaneously hypertensive Rats.
Kuriyama, S., Nakamura, K., Kaguchi, Y., Tomonari, H., Tokutome, G., Hashimoto, T., & Sakai, O. (1991) · Japanese Heart Journal · doi:10.1536/ihj.32.835 · Cited by 1
Another layer of ventricular heterogeneity? α1 agonists prolong repolarization in Purkinje fibers but not M-Cells
Colatsky, T. J. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(99)00190-x · Cited by 1
α1-Adrenergic regulation of peptidylglycine α-amidating monooxygenase gene expression in cultured rat cardiac myocytes: transcriptional studies and messenger ribonucleic acid stability
Girard, B. M., Ouafik, L., Delfino, C., Fraboulet, S., Oliver, C., & Boudouresque, F. (1999) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(99)00084-2 · Cited by 1
α1- and α2-Adrenoceptors in the Eye : Pharmacological and Functional Characterization
Wikberg-Matsson, A. (2001) · KTH Publication Database DiVA (KTH Royal Institute of Technology) · Cited by 1
Myocardial contractility and energetics in cardiac hypertrophy and its regression
Takeda, N., Iwai, T., Tanamura, A., Nakamura, I., Ohkubo, T., & Nagano, M. (1993) · Molecular and Cellular Biochemistry · doi:10.1007/bf00926361 · Cited by 1
Intracellular Signaling Through Protein Kinases in Cardiac Mechanotransduction
Sugden, P. H. (2007) · Springer eBooks · doi:10.1007/978-0-387-48868-4_8 · Cited by 1
[Long-term effects of a selective alpha 1-adrenergic inhibitor on right and left ventricular masses in patients with chronic pulmonary disease].
Nakamoto, T., Harasawa, H., Momoki, S., Suzuki, H., Horie, Y., Ohnuma, N., Ohno, K., Kato, S., Okuda, M., & Iizuka, M. (1997) · PubMed · Cited by 1
Paul Simpson
Jansen, J. M. (2019) · Circulation Research · doi:10.1161/circresaha.118.314619 · Cited by 1
Regulation of expression of contractile proteins with cardiac hypertrophy and failure
Martin, X. J., Wynne, D. G., Glennon, P. E., Moorman, A. F. M., & Boheler, K. R. (1996) · Springer eBooks · doi:10.1007/978-1-4613-1275-8_23 · Cited by 1
Alteration in Cardiac Renin-Angiotensin System in Spontaneously Hypertensive Rats (SHR)
Kudo, T., Okamoto, H., Mochizuki, N., Endo, Y., Sano, H., Iizuka, K., Shoki, M., Kawaguchi, H., Kitabatake, A., & Yasuda, H. (1992) · Springer eBooks · doi:10.1007/978-4-431-68219-6_51 · Cited by 1
Potential Role of Catecholamines in the Production of Physiological and Pathological Hypertrophy
Laks, M. M. (1987) · Developments in cardiovascular medicine · doi:10.1007/978-1-4613-2051-7_3 · Cited by 1
Growth factors and hypertension: Implications for a role in vascular remodelling
Amrani, A.-I. E., Amrani, F. E., & Cummins, P. L. (1993) · Developments in cardiovascular medicine · doi:10.1007/978-1-4615-3098-5_17
Akute kardiale Dyspnoe und Lungenödem
Beuckelmann, D. J. (2000) · Springer eBooks · doi:10.1007/978-3-662-12156-6_27
Pathophysiologie, Klinik und Prognose des Hochdruckherzens
Franz, I.-W. (1991) · Springer eBooks · doi:10.1007/978-3-642-76664-0_2
研究会第21回河口湖心臓討論会心肥大の成因 α 1 -アドレナリン受容体の心筋肥大における役割
Simpson, P. C. (1988) · 心臓 · doi:10.11281/shinzo1969.20.4_481
Efeito antiinflamatorio da S-nitroso-N-acetilcisteina (SNAC) na hipertrofia ventricular esquerda (HVE) em camundongos hipercolesterolemicos knockout para o receptor de LDL (LDLr-/-)
Garcia, J. A. D. (2006) · doi:10.47749/t/unicamp.2006.393942
Molekulare Mechanismen der kardialen Genexpression
Nadal‐Ginard, B., & Mahdavi, V. (1993) · Steinkopff eBooks · doi:10.1007/978-3-662-11145-1_5
CELLULAR TRAFFICKING PROPERTIES AND PHYSIOLOGICAL FUNCTIONS OF THE á1-ADRENOCEPTOR SUBTYPES
Chalothorn, D. (2003) · UKnowledge (University of Kentucky)
Participação da isoforma proteína quinase C βII na insuficiência cardíaca
Ferreira, J. C. B. (2009) · doi:10.11606/t.39.2009.tde-08092010-090610
The Role of the Sympathetic Nervous System in the Control of Left Ventricular Mass in Hypertension
Drayer, J. I. M., & Weber, M. A. (1985) · Steinkopff eBooks · doi:10.1007/978-3-642-53785-1_9
Receptor-Signaling Pathways in Heart Failure
Suvarna, S., Barki‐Harrington, L., Suzuki, M., Corvoisier, P. L., & Rockman, H. A. (2005) · Humana Press eBooks · doi:10.1007/978-1-59259-878-6_8
Aspects of Myocardial Infarction-induced Remodeling relevant to the Development of Heart Failure
Kalkman, E. A. J. (1997) · RePub (Erasmus University Rotterdam)
The Cardiovascular Continuum — Pathophysiology and Targets for Therapy
Unger, T. (2001) · Springer eBooks · doi:10.1007/978-3-642-56525-0_1
Wpływ insuliny na ekspresję transporterów nukleozydowych u szczura
Podgórska, M. (2006)
Lessons From Overexpressed Mouse Models
Perrino, C., Barki‐Harrington, L., & Rockman, H. A. (2006) · Humana Press eBooks · doi:10.1385/1-59259-931-1:293
Transgenic Mouse Models of Cardiovascular Function and Disease
Koch, W. J., & Blaxall, B. C. (2004) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-18934-0_12
The developmental changes of sympathetic β-adrenergic nervous system in the rat heart
Maie, S., Ohsuzu, F., Katsushika, S., & Nakamura, H. (1997) · Pathophysiology · doi:10.1016/s0928-4680(96)00139-3
Dual effect of heparin on cultured adult rat cardiomyocytes
Rezgui, N., Corda, S., Marotte, F., & Samuel, J. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20152
Protective effect of adenovirus-mediated heat shock protein 70 gene transfection against hypoxia/reoxygenation injury of cultured neonatal rat myocardiocytes
Yu, W., Yu, Y. A. N., Zhang, Y., & Qing, N. (2010) · Academic Journal of Second Military Medical University · doi:10.3724/sp.j.1008.2009.01344
Effect of .ALPHA.1-adrenoceptor blockade on the left ventricular force-length relationship in dogs.
Takeda, K., Shimizu, T., Nakamura, Y., Masuda, T., KONO, K., Takahashi, M., Makoto, O., & Yagi, S. (1992) · Japanese Circulation Journal-english Edition · doi:10.1253/jcj.56.929
Regression of established ventricular remodeling: A therapeutic goal in ventricular dysfunction?
McDonald, K. (1996) · Heart Failure Reviews · doi:10.1007/bf00126377
Influence of adrenoblockers on myocardial hypertrophy of the right and left ventricles of the heart in vasoprenal arterial hypertension
Ramdavon, P., Bakhilov, V. L., Дроздова, Г. А., & Фролов, В. А. (1993) · Pharmaceutical Chemistry Journal · doi:10.1007/bf00780553
Left ventricular hypertrophy and the insulin resistance syndrome
Sundström, J. (2001) · KTH Publication Database DiVA (KTH Royal Institute of Technology)
L’implication du Stromal Cell-derived Factor-1 alpha dans le remodelage cardiaque une semaine après un infarctus du myocarde
Proulx, C. (2008) · doi:10.71781/32017
Receptor-Mediated Hypertrophic Signaling Via Protein Kinase D and Histone Deacetylase 5 in Adult Myocytes
Chang, C.-W. (2012) · Loyola eCommons (Loyola University of Chicago)
Adrenergic stimulation and growth factor activity
Long, C. S., & Simpson, P. C. (1993) · Developments in cardiovascular medicine · doi:10.1007/978-1-4615-3098-5_19
Future Trends in Research in Hypertrophic Cardiomyopathy
Epstein, S. E. (1990) · Springer eBooks · doi:10.1007/978-3-642-83760-9_17
Myocardial Contractile Response and IP3, cAMP and cGMP Interrelationships
Martinussen, H. J. (1996) · Upsala Journal of Medical Sciences · doi:10.3109/03009739609178912
Novel approaches to study myocardial hypertrophy towards development of anti‐hypertensive drugs: Expression of myosin light chain genes during cardiac hypertrophy
Kumar, C. C. (1989) · Drug Development Research · doi:10.1002/ddr.430180403
Significance of Adrenergic Stimuli for Cardiac Remodeling under Chronic Overload: Relative Importance of Myocardial Factors versus Ventricular Geometry in Cardiac Failure
Brändle, M., Dierberger, B., Mall, G., & Jacob, R. (1995) · Developments in cardiovascular medicine · doi:10.1007/978-1-4613-1237-6_29
Aus dem Institut für Experimentelle und Klinische Pharmakologie und Toxikologie Universitätsklinikum Hamburg-Eppendorf
Eschenhagen, T. (2009)
mechanics of skeletal muscle resistance arteries Chronic intermittent hypoxia alters NE reactivity and
Phillips, S. A., Olson, E. B., Lombard, J. H., Morgan, B. J., Am, J., Mifflin, W., Toney, G. M., Sharpe, A. L., Calderon, A. S., Andrade, M. A., et al. (2013)
Regulation of the Inositol 1,4,5-Trisphosphate growth signaling pathway in cardiomyocytes
Vasilevski, O. (2008) · Swinburne figshare (Swinburne University of Technology) · doi:10.25916/sut.26288914
ACTA UNIVERSITATIS OULUENSIS D Medica 1324
Stretch, M., & Growth, P. (2015)
ALPHA-1-ADRENERGIC BLOCKADE BUNAZOSIN BUT NOT HYDRALAZINE IMPROVES CARDIAC HYPERTROPHY IN A RAT MODEL OF MYOCARDIAL INFARCTION
Imanari, T. (1994) · Kitakantou igaku/Kitakantō Igaku · doi:10.2974/kmj1951.44.317
Functional and Metabolic Effects of Norepinephrine on the Rat Heart
Zimmer, H. (1996) · Developments in cardiovascular medicine · doi:10.1007/978-1-4613-1235-2_3
Regulation of Myocardial Function in Health and Critical Illness
Williams, G. A., & Ayres, S. M. (1985) · Critical Care Clinics · doi:10.1016/s0749-0704(18)30638-9
Der positiv inotrope Effekt von Insulin am menschlichen Myokard
Kania, S. M. A. (2016) · doi:10.53846/goediss-5682
THE EFFECT OF RUNNING TRAINING ON REGIONAL CARDIAC MYOSIN ISOZYME COMPOSITION IN RATS
Machida, S., Kobayashi, K., & Narusawa, M. (2000) · 体力科學 · doi:10.7600/jspfsm1949.49.247
Definition und Epidemiologie der chronischen Herzinsuffizienz
Böhm, M., & Erdmann, E. (2000) · Springer eBooks · doi:10.1007/978-3-662-12156-6_28
In Vitro Human Engineered Myocardium: A Study into both Pathological and Physiological Hypertrophy
Miklas, J. W. (2013) · TSpace (University of Toronto)
Characterizing Rho Kinase Activity Using a Novel PET Tracer in Hypertrophied Cardiomyocytes
Moreau, S. (2012) · uO Research (University of Ottawa) · doi:10.20381/ruor-5810 · Cited by 1
Quinazoline α1-Blockers: Are there any News about their Efficacy in Inhibiting Prostate Tumor Growth?
Alberti, C., Chiapello, G., Bernardi, D., Mediago, M., & Arena, G. (2006) · Urologia Journal · doi:10.1177/039156030607300402
Differential signal transductions of adrenoceptors in ischemia-reperfused heart and hypoxia-reoxygenated cardiomyocytes
김미진 (2007)
The Effects of Diminished Pulsatility in Long-Term Continuous-Flow Left Ventricular Assist Device Recipients
Grosman‐Rimon, L. (2014) · TSpace (University of Toronto)
Influência do sistema renina angiotensina na redução da hipertrofia de ventrículo esquerdo em indivíduos hiperreatores
Avanza, A. C. (2005) · doi:10.11606/t.5.2005.tde-03102014-144615

Authors: Simpson, P.
Affiliations: San Francisco VA Medical Center (US)
Corresponding author: Simpson, P
ORCID: Simpson, P
Venue: Journal of Clinical Investigation
Publisher: American Society for Clinical Investigation
Published: 1983-08-01
Volume: 72
Issue: 2
Pages: 732-738
ISSN: 0021-9738 (ISSN-L)
DOI: 10.1172/jci111023
PMC: PMC1129233
OpenAlex: W2110889457
Cited by: 618
References: 20
Citations by year: 2026: 4 · 2025: 3 · 2024: 3 · 2023: 2 · 2022: 6 · 2021: 5 · 2020: 5 · 2019: 7 · 2018: 3 · 2017: 4 · 2016: 5 · 2015: 5 · 2014: 3 · 2013: 10 · 2012: 6
FWCI: 3.65
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Journal of Clinical Investigation (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: University of California, San Francisco
National Heart, Lung, and Blood Institute (R01HL031113)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
Keywords: norepinephrine, cardiac hypertrophy, alpha1-adrenoceptors, alpha-blockers, phentolamine, prazosin, terazosin, yohimbine, isoproterenol, propranolol
MeSH terms: Adrenergic alpha-Antagonists, Animals, Cardiomegaly, Isoproterenol, Myocardium, Norepinephrine, Phentolamine, Prazosin, Propranolol, Receptors, Adrenergic, Receptors, Adrenergic, alpha, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Norepinephrine-stimulated hypertrophy of cultured rat myocardial cells is an alpha-1 adrenergic response

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks